Alexion Pharmaceuticals, Inc. (ALXN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
129.17-2.95 (-2.23%)
At close: 4:00 PM EDT
People also watch:
REGNBMRNVRTXBIIBCELG
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open132.19
Prev Close132.12
Bid128.00 x 1000
Ask139.12 x 400
Day's Range127.47 - 133.43
52wk Range110.56 - 193.45
1y Target EstN/A
Market Cap28.97B
P/E Ratio (ttm)324.55
Beta1.28
Volume1,612,865
Avg Vol (3m)1,981,562
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Investopedia3 hours ago

    Tesla Tops Forbes' 2016 List of Most Innovative Companies (TSLA, CRM)

    Forbes has released its sixth annual "World’s Most Innovative Companies" and Tesla tops the list.

  • Zacks4 days ago

    New Strong Sell Stocks for August 22nd

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday

  • Barrons.com6 days ago

    Biotech Stocks: Trouble Ahead, Trouble Behind?

    Piper Jaffray's Joshua Schimmer and team note that biotech stocks like Gilead Sciences (GILD), Celgene (CELG), and Alexion Pharmaceuticals (ALXN) are too cheap to ignore despite "challenges on the horizon." They explain: In a frothy equities market that seems paradoxical to economic indicators, biotech stands out as relatively undervalued, by a considerable amount in our view. In an frothy tape, we shift towards value, either with Gilead's 7x P/E ratio or Alexion and Celgne's